• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tectonic Therapeutic, Inc. - Common Stock (NQ:TECX)

20.56 -0.90 (-4.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tectonic Therapeutic, Inc. - Common Stock

News headline image
Tectonic Therapeutic to Participate in December Investor Conferences
December 01, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
November 06, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
October 29, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Participate in September Investor Conferences
August 28, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights
August 07, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Joins Russell 3000® Index
June 30, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
May 17, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
May 08, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
May 07, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
April 15, 2025
Late-breaking oral presentation to include full Phase 1b results for TX45 in the Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) cohort 
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 20, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Participate in March Investor Conferences
February 20, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Announces $185 Million Private Placement
February 03, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
January 30, 2025
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
December 03, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
November 26, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
November 11, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
November 07, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
October 22, 2024
American Heart Association (AHA) poster to be presented on November 16, 2024 
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
September 19, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Participate in September Investor Conferences
August 20, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
August 14, 2024
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
July 30, 2024
From Tectonic Therapeutic
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap